Identification of nine new susceptibility loci for endometrial cancer

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  O’Mara, Tracy A ^a   Glubb, Dylan M ^a   Amant, Frederic ^b   Annibali, Daniela ^b   Ashton, Katie ^c,d   Attia, John ^c,e   Auer, Paul L ^f,g   Beckmann, Matthias W ^h   Black, Amanda ⁱ   Bolla, Manjeet K ^j   Brauch, Hiltrud ^k,l,m   Brenner, Hermann ^m   Brinton, Louise ⁱ   Buchanan, Daniel D ^n,o,p   Burwinkel, Barbara ^m,q   Chang Claude, Jenny ^m,r   Chanock, Stephen J ⁱ   Chen, Chu ^f   Chen, Maxine M ^s   Cheng, Timothy H T ^t   Clarke, Christine L ^u   Clendenning, Mark ⁿ   Cook, Linda S ^v,w   Couch, Fergus J ^x   Cox, Angela ^y   Crous Bous, Marta ^s,z   Czene, Kamila ^aa   Day, Felix ^ab   Dennis, Joe ^j   Depreeuw, Jeroen ^b,ac,ad   Doherty, Jennifer Anne ^ae   Dörk, Thilo ^af   Dowdy, Sean C ^x   Dürst, Matthias ^ag   Ekici, Arif B ^h   Fasching, Peter A ^h,ah   Fridley, Brooke L ^ai   Friedenreich, Christine M ^w   Fritschi, Lin ^aj   Fung, Jenny ^ak   García Closas, Montserrat ^i,al   Gaudet, Mia M ^am   Giles, Graham G ^o,an,ao   Goode, Ellen L ^x   Gorman, Maggie ^t   Haiman, Christopher A ^ap   Hall, Per ^aa,aq   Hankison, Susan E ^z,ar   Healey, Catherine S ^j   Hein, Alexander ^h   Hillemanns, Peter ^af   Hodgson, Shirley ^as   Hoivik, Erling A ^at,au   Holliday, Elizabeth G ^c,e   Hopper, John L ^o   Hunter, David J ^s   Jones, Angela ^t   Krakstad, Camilla ^at,au   Kristensen, Vessela N ^av,aw,ax   Lambrechts, Diether ^ac,ad   Marchand, Loic Le ^ay   Liang, Xiaolin ^az   Lindblom, Annika ^aa   Lissowska, Jolanta ^ba   Long, Jirong ^bb   Lu, Lingeng ^bc   Magliocco, Anthony M ^bd   Martin, Lynn ^be   McEvoy, Mark ^e   Meindl, Alfons ^bf   Michailidou, Kyriaki ^j,bg   Milne, Roger L ^o,an   Mints, Miriam ^aa   Montgomery, Grant W ^a,ak   Nassir, Rami ^bh   Olsson, Håkan ^bi   Orlow, Irene ^az   Otton, Geoffrey ^e   Palles, Claire ^t   Perry, John R B ^ab   Peto, Julian ^bj   Pooler, Loreall ^ap   Prescott, Jennifer ^z   Proietto, Tony ^e   Rebbeck, Timothy R ^s,bk   Risch, Harvey A ^bc   Rogers, Peter A W ⁿ   Rübner, Matthias ^h   Runnebaum, Ingo ^ag   Sacerdote, Carlotta ^bl,bm   Sarto, Gloria E ^bn   Schumacher, Fredrick ^bo   Scott, Rodney J ^c,d   Setiawan, V Wendy ^ap   Shah, Mitul ^j   Sheng, Xin ^ap   Shu, Xiao Ou ^bb   Southey, Melissa C ^n,ao   Swerdlow, Anthony J ^al   Tham, Emma ^aa   Trovik, Jone ^at,au   Turman, Constance ^s   Tyrer, Jonathan P ^j   Vachon, Celine ^x   VanDen Berg, David ^ap   Vanderstichele, Adriaan ^b   Wang, Zhaoming ⁱ   Webb, Penelope M ^a   Wentzensen, Nicolas ⁱ   Werner, Henrica M J ^at,au   Winham, Stacey J ^x   Wolk, Alicja ^aa   Xia, Lucy ^ap   Xiang, Yong Bing ^bp   Yang, Hannah P ⁱ   Yu, Herbert ^ay   Zheng, Wei ^bb   Pharoah, Paul D P ^j   Dunning, Alison M ^j   Kraft, Peter ^s   De Vivo, Immaculata ^s,z   Tomlinson, Ian ^t,be   Easton, Douglas F ^j   Spurdle, Amanda B ^a   Thompson, Deborah J ^j   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c JOHN HUNTER HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f USA   (United States)

^g UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^l UNIVERSITY OF TÜBINGEN   (Germany)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

^o UNIVERSITY OF MELBOURNE   (Australia)

^p ROYAL MELBOURNE HOSPITAL   (Australia)

^q UNIVERSITY OF HEIDELBERG   (Germany)

^r UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^s HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u UNIVERSITY OF SYDNEY   (Australia)

^v UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^w ALBERTA HEALTH SERVICES   (Canada)

^x MAYO CLINIC   (United States)

^y UNIVERSITY OF SHEFFIELD   (United Kingdom)

^z BRIGHAM AND WOMEN S HOSPITAL   (United States)

^aa KAROLINSKA INSTITUTE   (Sweden)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^ad UNIVERSITY OF LEUVEN   (Belgium)

^ae UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^af HANNOVER MEDICAL SCHOOL   (Germany)

^ag FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^ah UNIVERSITY OF CALIFORNIA   (United States)

^ai UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^aj CURTIN UNIVERSITY   (Australia)

^ak UNIVERSITY OF QUEENSLAND   (Australia)

^al INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^am AMERICAN CANCER SOCIETY   (United States)

^an CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ao MONASH UNIVERSITY   (Australia)

^ap UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aq STOCKHOLM SÖDER HOSPITAL   (Sweden)

^ar UNIVERSITY OF MASSACHUSETTS   (United States)

^as ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^at UNIVERSITY OF BERGEN   (Norway)

^au HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^av OSLO UNIVERSITY HOSPITAL   (Norway)

^aw UNIVERSITY OF OSLO   (Norway)

^ax UNIVERSITY OF OSLO   (Norway)

^ay UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^az MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ba INSTITUTE OF ONCOLOGY   (Poland)

^bb VANDERBILT INGRAM CANCER CENTER   (United States)

^bc YALE UNIVERSITY   (United States)

^bd H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^be UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^bf UNIVERSITY OF MUNICH   (Germany)

^bg CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^bh UNIVERSITY OF CALIFORNIA   (United States)

^bi LUND UNIVERSITY   (Sweden)

^bj LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^bk DANA FARBER CANCER INSTITUTE   (United States)

^bl Center for Cancer Prevention CPO Piemonte   (Italy)

^bm Human Genetics Foundation   (Italy)

^bn UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^bo CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bp SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; GENE; GENE EXPRESSION; GENOME; GENOTYPE; IDENTIFICATION METHOD; META-ANALYSIS;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; EXPRESSION QUANTITATIVE TRAIT LOCUS; GENE EXPRESSION; GENE LOCUS; GENETIC IDENTIFICATION; GENETIC RISK; HUMAN; SIGNAL TRANSDUCTION; CHEMISTRY; CHROMATIN; ENDOMETRIUM TUMOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; QUANTITATIVE TRAIT LOCUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

TUMOR MARKER;

ALLELES; BIOMARKERS, TUMOR; CHROMATIN; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 85051554034     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-05427-7     Document Type: Article

References (59)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386 (2015)
2. Win, A. K., Reece, J. C. & Ryan, S. Family history and risk of endometrial cancer: a systematic review and meta-analysis. Obstet. Gynecol. 125, 89–98 (2015)
3. Johnatty, S. E. et al. Family history of cancer predicts endometrial cancer risk independently of Lynch syndrome: implications for genetic counselling. Gynecol. Oncol. 147, 381–387 (2017)
4. Spurdle, A. B., Bowman, M. A., Shamsani, J. & Kirk, J. Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing. Mod. Pathol. 30, 1048–1068 (2017)
5. Chen, M. M. et al. GWAS meta-analysis of 16852 women identifies new susceptibility locus for endometrial cancer. Hum. Mol. Genet. 25, 2612–2620 (2016)
6. Cheng, T. H. et al. Five endometrial cancer risk loci identified through genome-wide association analysis. Nat. Genet. 48, 667–674 (2016)
7. Painter, J. N. et al. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum. Mol. Genet. 24, 1478–1492 (2015)
8. Thompson, D. J. et al. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocr. Relat. Cancer 23, 77–91 (2016)
9. Cheng, T. H. et al. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. Sci. Rep. 5, 17369 (2015)
10. Painter, J. N. et al. A common variant at the 14q32 endometrial cancer risk locus activates AKT1 through YY1 binding. Am. J. Hum. Genet. 98, 1159–1169 (2016)
11. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011)
12. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013)
13. Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67–73 (2013)
14. Fung, J. N. et al. The genetic regulation of transcription in human endometrial tissue. Hum. Reprod. 32, 893–904 (2017)
15. Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238–1243 (2013)
16. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012)
17. Sapkota, Y. et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat. Commun. 8, 15539 (2017)
18. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014)
19. Day, F. R. et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat. Genet. 49, 834–841 (2017)
20. Painter, J. N. et al. Genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 25, 1503–1510 (2016)
21. Zhang, B. et al. Height and breast cancer risk: evidence from prospective studies and Mendelian randomization. J. Natl Cancer Inst. 107, djv219 (2015)
22. Khankari, N. K. et al. Association between adult height and risk of colorectal, lung, and prostate cancer: results from meta-analyses of prospective studies and mendelian randomization analyses. PLoS Med. 13, e1002118 (2016)
23. Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017)
24. Wrzeszczynski, K. O. et al. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PLoS ONE 6, e28503 (2011)
25. Ruchaud, S., Carmena, M. & Earnshaw, W. C. Chromosomal passengers: conducting cell division. Nat. Rev. Mol. Cell Biol. 8, 798–812 (2007)
26. So, J. et al. Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy. Sci. Signal. 8, rs3 (2015)
27. Agrawal, P., Yu, K., Salomon, A. R. & Sedivy, J. M. Proteomic profiling of Myc-associated proteins. Cell Cycle 9, 4908–4921 (2010)
28. McCarty, G. & Loeb, D. M. Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells. PLoS ONE 10, e0119837 (2015)
29. Moorwood, K. et al. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro. J. Pathol. 185, 352–359 (1998)
30. Devalliere, J. & Charreau, B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem. Pharmacol. 82, 1391–1402 (2011)
31. Rad, E. & Tee, A. R. Neurofibromatosis type 1: fundamental insights into cell signalling and cancer. Semin. Cell Dev. Biol. 52, 39–46 (2016)
32. Setiawan, V. W. et al. Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol. 31, 2607–2618 (2013)
33. De Vivo, I. et al. Genome-wide association study of endometrial cancer in E2C2. Hum. Genet. 133, 211–224 (2014)
34. Amos, C. I. et al. The OncoArray Consortium: a network for understanding the genetic architecture of common cancers. Cancer Epidemiol. Biomarkers Prev. 26, 126–135 (2017)
35. Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92–94 (2017)
36. Milne, R. L. et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat. Genet. 49, 1767–1778 (2017)
37. Delaneau, O., Marchini, J., 1000 Genomes Project Consortium & 1000 Genomes Project Consortium. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Nat. Commun. 5, 3934 (2014)
38. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2012)
39. Fuchsberger, C., Abecasis, G. R. & Hinds, D. A. minimac2: faster genotype imputation. Bioinformatics 31, 782–784 (2015)
40. O’Connell, J. et al. Haplotype estimation for biobank-scale data sets. Nat. Genet. 48, 817–820 (2016)
41. Bycroft, C. et al. Genome-wide genetic data on ~500,000 UK Biobank participants. Preprint at https://www.biorxiv.org/content/early/2017/07/20/166298 (2017)
42. Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499–511 (2010)
43. Aulchenko, Y. S., Struchalin, M. V. & van Duijn, C. M. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11, 134 (2010)
44. Liu, J. Z. et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 42, 436–440 (2010)
45. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012)
46. Wakefield, J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet. 81, 208–227 (2007)
47. Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015)
48. Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat. Med. 35, 1880–1906 (2016)
49. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015)
50. Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015)
51. Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014)
52. Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017)
53. Day, F. R. et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat. Genet. 47, 1294–1303 (2015)
54. Burgess, S. et al. Dissecting causal pathways using Mendelian randomization with summarized genetic data: application to age at menarche and risk of breast cancer. Genetics 207, 481–487 (2017)
55. Carvajal-Carmona, L. G. et al. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum. Genet. 134, 231–245 (2015)
56. Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443–1448 (2016)
57. Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016)
58. Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012)
59. Li, Q. et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633–641 (2013)